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Abstract. 
 
Among the nuclear proteins associated with 
mRNAs before their export to the cytoplasm are the 
abundant heterogeneous nuclear (hn) RNPs. Several of 
these contain the M9 signal that, in the case of hnRNP 
A1, has been shown to be sufficient to signal both nu-
clear export and nuclear import in cultured somatic 
cells. Kinetic competition experiments are used here to 
demonstrate that M9-directed nuclear import in 
 
Xeno-
pus
 
 oocytes is a saturable process. Saturating levels of 
M9 have, however, no effect on the import of either U 
snRNPs or proteins carrying a classical basic NLS. Pre-
vious work demonstrated the existence of nuclear ex-
port factors specific for particular classes of RNA. In-
jection of hnRNP A1 but not of a mutant protein 
lacking the M9 domain inhibited export of mRNA but 
not of other classes of RNA. This suggests that hnRNP 
A1 or other proteins containing an M9 domain play a 
role in mRNA export from the nucleus. However, the 
requirement for M9 function in mRNA export is not 
identical to that in hnRNP A1 protein transport.
 
T
 
he
 
 transport of macromolecules between the nu-
cleus and cytoplasm is a bi-directional process. The
best understood aspect is the import of nuclear pro-
teins that carry a basic nuclear localization signal (NLS)
 
1
 
like the simple NLS found in SV-40 T antigen or the bipar-
tite NLS found in nucleoplasmin (Dingwall and Laskey,
1991). Proteins of this class are recognized by the hetero-
dimeric importin receptor, composed of importin 
 
a
 
 and
importin 
 
b
 
 (for review see Powers and Forbes, 1994; Mel-
chior and Gerace, 1995; Görlich and Mattaj, 1996). The
NLS binds directly to the importin 
 
a
 
 subunit. The importin
NLS protein complex docks at the cytoplasmic face of the
nuclear pore complex in an energy-independent manner
(Newmeyer and Forbes, 1988; Richardson et al., 1988).
Subsequently, the small GTPase Ran/TC4 (Melchior et al.,
1993; Moore and Blobel, 1993) and a protein of unknown
function named variously pp15, p10, or NTF2 (Moore and
Blobel, 1994; Paschal and Gerace, 1995) are required for
translocation of the NLS-containing complex through the
nuclear pore complex.
A second major class of imported macromolecules are
the uracil rich small nuclear (U sn) RNPs. They do not
have a basic NLS but instead have a bipartite nuclear tar-
geting signal. This is composed of an essential signal
formed when the Sm core proteins bind to the U snRNA
and an additional signal, the trimethyl-guanosine (m
 
3
 
G)
cap, which depending on the cell type or the U snRNA is
either essential or required for optimal U snRNP import
efficiency (Fischer and Lührmann, 1990; Hamm et al.,
1990; Fischer et al., 1993). Kinetic competition experi-
ments have supported the conclusion that U snRNPs re-
quire different limiting factors than do NLS-containing
proteins for their import and that U snRNPs do not bind
to importin 
 
a
 
 (Fischer et al., 1991, 1993; Michaud and
Goldfarb, 1991; van Zee et al., 1993). There is also prelim-
inary evidence that additional different receptors may be
required for the nuclear uptake of other RNA species
(Michaud and Goldfarb, 1992).
Similarly, RNA export from the nucleus relies on recog-
nition of the RNA or RNP export substrates by saturable
factors (Zasloff, 1983; Bataillé et al., 1990; Jarmolowski et al.,
1994). As for import, evidence for the existence of RNA
class-specific export receptors has been obtained from ki-
netic competition experiments (Jarmolowski et al., 1994).
Two RNA-binding proteins have been directly shown to
function in RNA export, a nuclear cap binding protein
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: CBC, cap binding complex; hn, heter-
ogenous nuclear; IBB, importin 
 
b
 
 binding; m
 
3
 
G, methyl
 
2,2,7
 
guanosine;
NES, nuclear export signal; NLS, nuclear localization signal; NPLc, nucle-
oplasmin core domain; U sn, uracil rich small nuclear.
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complex in the case of U snRNAs (Izaurralde et al., 1995
 
a
 
)
and the HIV-1 Rev protein in the case of RNAs contain-
ing a rev response element (Fischer et al., 1994, 1995). In
the case of mRNAs, the best candidates for export media-
tors are the heterogeneous nuclear (hn) RNP proteins (for
review see Piñol-Roma and Dreyfuss, 1993; Izaurralde and
Mattaj, 1995).
About 20 different hnRNP proteins have been charac-
terized in vertebrate cells (for review see Dreyfuss et al.,
1993). The association of hnRNP proteins with mRNA in
the nucleus and the cytoplasm suggests that they may reg-
ulate and/or facilitate different aspects of gene expression.
The possibility that hnRNP proteins might be directly in-
volved in the nucleocytoplasmic trafficking of mRNA
molecules was suggested by the observation that several
hnRNP proteins, including A1, A2, D, E, I, and K shuttle
continuously and rapidly between the nucleus and the cy-
toplasm and are associated with mRNA in both compart-
ments (Piñol-Roma and Dreyfuss 1992, 1993; Michael et
al., 1995
 
a
 
, 
 
b
 
). Of these, the best studied example is hnRNP
A1. An A1-like hnRNP protein has been shown by immu-
noelectron microscopy to be associated with a specific
mRNA in transit to the cytoplasm through the nuclear
pore complex in the insect 
 
Chironomus tentans
 
 (Visa et al.,
1996
 
a
 
). In mammalian cells, the amount of A1 which is in
constant flux between nucleus and cytoplasm is striking. It
has been estimated that at least 120,000 molecules of A1
are exported to the cytoplasm per minute but then rapidly
reimported such that the steady state localization of A1 is
nuclear (Michael et al., 1995
 
a
 
). Taken together, these re-
sults suggest that A1 and other shuttling hnRNP proteins
such as A2, D, E, I, and K could play a significant role in
the transport of mRNA from the nucleus to the cytoplasm.
One key in understanding how hnRNPs may facilitate
mRNA export is to determine the signals that mediate their
shuttling, i.e., their import into and exit from the nucleus.
The nucleocytoplasmic transport of A1 has been recently
studied in detail, and the signals that mediate shuttling
have been identified (Michael et al., 1995
 
b
 
; Siomi and
Dreyfuss, 1995; Weighardt et al., 1995). Nuclear import of
A1 is determined by a 38-amino acid sequence, termed
M9, located near the COOH terminus of the protein be-
tween amino acids 268 and 305. Its fusion to cytoplasmic
reporter proteins such as pyruvate kinase resulted in rapid
import of the fusion protein into the nucleus (Siomi and
Dreyfuss, 1995). However, the A1 NLS has no sequence
similarity to classical protein NLSs such as that of SV-40
large T antigen or nucleoplasmin (Siomi and Dreyfuss, 1995).
Surprisingly, M9 also acts as a nuclear export signal
(NES). In heterokaryon shuttling assays this domain is
necessary and sufficient to allow the export of heterolo-
gous proteins, such as the nucleoplasmin core domain
(NPLc), which are normally retained in the nucleus
(Michael et al., 1995
 
b
 
). Thus, M9 alone can account for the
shuttling of A1. Other hnRNPs such as A2 and B1 bear se-
quences with striking similarities to M9 (Siomi and Drey-
fuss, 1995). Mutagenesis experiments indicate that the NES
and NLS activities of M9 are either identical or overlap-
ping as mutants which block M9 NLS activity also abolish
NES activity (Michael et al., 1995
 
b
 
). It is therefore possi-
ble that M9 is recognized in the nucleus and the cytoplasm
by the same receptor.
The second category of NES described was first found in
the HIV-1 Rev protein and the inhibitor of protein kinase
A (Fischer et al., 1995; Wen et al., 1995; Bogerd et al., 1996;
for review see Gerace, 1995). These short, leucine-rich
NES sequences bear no relationship to the primary se-
quence of M9. Furthermore, saturation of the export fac-
tor recognized by the Rev NES has no effect on mRNA
export (Fischer et al., 1995). A model for mRNA export
has been postulated on the basis of the hnRNP data de-
scribed above. In this model, NES/NLS containing hnRNPs
bind in the nucleus to mRNA molecules and deliver them,
via the export pathway they access, to the cytoplasm. In
the cytoplasm these hnRNP proteins dissociate from the
mRNA and return to the nucleus. To further test this model
we have analyzed the transport of hnRNP A1 and mRNA
in 
 
Xenopus laevis
 
 oocytes. The oocyte offers a unique op-
portunity to manipulate specific import or export path-
ways, like that accessed by M9, and examine the effect on
mRNA nuclear export. By using this approach we show
here that M9 is, as in somatic cells, a functional NLS in oo-
cytes. Moreover, competition studies indicate that M9 de-
fines a novel class of NLS, since saturation of the M9-
mediated import pathway does not interfere with the two
previously identified import pathways used by classical
NLS-bearing proteins or m
 
3
 
G-capped-spliceosomal U sn-
RNPs. Injection of an excess of hnRNP A1 but not of a
mutant form of the protein lacking the M9 domain, re-
sulted in a specific inhibition of mRNA export, demon-
strating that the M9 domain is recognized by a saturable
component of the mRNA export machinery. The export of
other cellular RNAs such as U snRNAs and tRNA was, in
contrast, not affected. Further analysis of mutant hnRNP
A1 proteins provides evidence that M9 recognition during
mRNA export differs from its recognition during protein
transport.
 
Materials and Methods
 
All enzymes used for DNA manipulations were purchased from New En-
gland Biolabs Inc. (Beverly, MA). T7 RNA polymerase and RNasin were
from Stratagene (La Jolla, CA). AmpliTaq DNA polymerase was from
Perkin-Elmer Cetus (Norwalk, CT). The cap analogue m
 
7
 
GpppG and the
modified nucleotide 
 
g
 
-mGTP used to prime the synthesis of DHFR
mRNA, U1
 
D
 
Sm, U5
 
D
 
Sm, and U6
 
D
 
ss, respectively, were a kind gift of E.
Darzynkiewicz (Institute of Experimental Physiology, Warsaw, Poland). La-
beled nucleoside triphosphates and [
 
35
 
S]methionine were from Amersham
Corp. (Arlington Heights, IL). Sequences were determined using the di-
deoxynucleotide chain termination method (Sanger et al., 1977) and T7
DNA polymerase (Pharmacia LKB, Freiburg, Germany). Isolation of
plasmid DNA, cloning, transformation of 
 
Escherichia coli
 
, and gel analy-
sis of recombinant plasmids were performed as described by Sambrook et
al. (1989). Reverse transcription and PCR were performed as described
(Frohman, 1990). Peptide synthesis and coupling to BSA was performed
as described (Fischer et al., 1995). The sequence of the NLS peptide was
as follows: CGGGPKKKRKVED and that of the NLSrev: CGGGDE-
VKRKKKP.
 
Recombinant Protein Expression and Plasmid DNAs
 
The recombinant IBB domain, amino acids 1–55 of 
 
Xenopus
 
 importin 
 
a
 
,
fused to the IgG binding z domain of protein A and the truncated impor-
tin 
 
b
 
 binding (IBB) fusion corresponding to amino acids 1–43 of 
 
Xenopus
 
importin 
 
a
 
 were a kind gift of D. Görlich (Zentrum für Molekulare Biologie,
Heidelberg, Germany). For expression in 
 
E. coli
 
 and in vitro translation,
cDNAs encoding the full length human hnRNP A1, the hnRNP A1 M9mu
(Gly 274 mutated to Ala), or amino acids 1–236 (hnRNP A1
 
D
 
M9) were in-
troduced by PCR between the BamHI and HindIII sites of either the pRSETA 
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or pRSETB vectors (Invitrogen Corp., San Diego, CA). The pRSETB
constructs used in Fig. 7 
 
C
 
 have an EcoRI site (Glu–Phe) inserted be-
tween amino acids 267 and 268 of the hnRNP A1 sequence. The nucleo-
plasmin core–M9 fusion construct used in Fig. 1 was obtained by cloning
cDNAs encoding amino acids 1–149 of 
 
Xenopus
 
 nucleoplasmin and amino
acids 255–320 of human hnRNP A1 (including the M9 domain) between
the NheI–BamHI and BamHI–HindIII sites of pRSETA vector, respec-
tively. For in vitro transcription the DNA was linearized with HindIII and
transcribed with T7 RNA polymerase, and the resulting RNA was trans-
lated in vitro.
HnRNP A1, hnRNP A1
 
D
 
M9, hnRNP A1 M9mu, and NPLc-M9 were
expressed from the pRSET constructs described above and purified by
their 6 X His tag on Ni-NTA agarose beads (Qiagen, Chatsworth, CA) ac-
cording to the instructions of the manufacturer. Elution of recombinant
proteins was performed in PBS buffer containing 0.5 M imidazole (Sigma
Chemical Co., St. Louis, MO). Recombinant proteins were concentrated
and desalted using microconcentrator devices (Pall Filtron Technology
Corporation, Northborough, MA).
The hnRNP A1 construct used in Fig. 2 and the plasmids PK-M9 and
PK-M9mu, have been described previously (Michael et al., 1995
 
b
 
; Siomi
and Dreyfuss, 1995). In these PK-M9 constructs, the M9 domain (amino
acids 268–305 of hnRNP A1) was cloned at the KpnI site corresponding to
codon 443 of chicken muscle pyruvate kinase and was functional, however
we have observed that when amino acids 255–320 of hnRNP A1 were
inserted at the COOH terminus of pyruvate kinase, the fusion was no
longer functional. The plasmid encoding glutathione-S-transferase (GST-
M9) was made by inserting the EcoRI–XhoI fragment of PK-M9 into the
pGEX-5X-1 vector (Pharmacia Fine Chemicals, Piscataway, NJ). The GST-
M9mu plasmid, which contains an amino acid substitution Gly 274 to Ala
in the M9 domain (Michael et al., 1995
 
b
 
), was constructed by ligation of
the EcoRI–XhoI fragment of PK-M9mu (Gly to Ala) into pGEX-5X-1.
All GST fusion proteins were expressed under standard conditions as de-
scribed by the manufacturers (Pharmacia Fine Chemicals). All constructs
obtained by PCR were fully sequenced.
 
In Vitro Transcription and Translation
 
For generation of 
 
35
 
S-labeled in vitro translated fusion proteins, the com-
bined in vitro transcription/translation (TNT) kit from Promega Biotech.
(Madison, WI) was used. In brief, 1 
 
m
 
g of plasmid DNA containing the
gene to be transcribed and translated was incubated in a total volume of
50 
 
m
 
l containing 25 
 
m
 
l reticulocyte lysate, 2 
 
m
 
l TNT-polymerase, 2 
 
m
 
l reac-
tion buffer, 2 
 
m
 
l amino acid mix lacking methionine, 40 
 
m
 
Ci [
 
35
 
S]methio-
nine (Amersham Corp.) and 1 
 
m
 
l (10 U) RNasin (Promega Biotech.). The
reaction was carried out at 30
 
8
 
C for 2 h. Translation was checked by SDS-
 
PAGE and subsequent fluorography using intensify solutions from Du-
Pont (Wilmington, DE). In vitro translated proteins were injected directly
into oocytes without further purification.
 
3
 
9
 
 End Labeling of Gel-purified U snRNAs
 
1 
 
m
 
g of gel purified U snRNA was assayed for 3
 
9
 
 end labeling as described
previously (Fischer et al., 1993) in a buffer containing 50 mM Hepes-
KOH, pH 7.9, 18 mM MgCl
 
2
 
, 3 mM DTE, 10 
 
m
 
g/ml BSA, 1 U/
 
m
 
l T4 RNA
ligase (GIBCO BRL, Gaithersburg, MD) and 60 
 
m
 
Ci [
 
32
 
P]pCp (3,000 Ci/
mMol; Amersham Corp.). The assay mixture was incubated for 18 h at
4
 
8
 
C. The RNA was ethanol precipitated, resuspended in water, and used
for injection.
 
Oocyte Injections
 
Oocyte injections and analysis of microinjected RNA by denaturing gel
electrophoresis, autoradiography, or phosphoimager analysis were per-
formed as described (Fischer et al., 1993; Jarmolowski et al., 1994). The
concentration of the recombinant proteins in the injected samples is indi-
cated in the figure legends. Microinjection of in vitro translated protein
into oocytes, isolation of protein from oocytes, and SDS-PAGE analysis
were all carried out as described (Kambach and Mattaj, 1992; Fischer et al.,
1993). The mutant RNAs used (U1
 
D
 
Sm, U5
 
D
 
Sm, U6
 
D
 
ss) lack protein bind-
ing sites required for the nuclear import of these RNAs (Hamm et al.,
1990; Jarmolowski and Mattaj, 1993) and thus remain in the cytoplasm af-
ter export from the nucleus.
 
Results
 
The M9 Domain of hnRNP A1 Serves as a Nuclear 
Import Signal in Oocytes
 
Nucleocytoplasmic transport of hnRNPs has so far only been
examined in somatic cells. To test whether the M9 domain
of hnRNP A1 is able to mediate nuclear import in oocytes,
in vitro translated 
 
35
 
S-labeled, full length human hnRNP
A1 protein or a truncated form (aa1–236) lacking the M9
domain (termed hnRNP A1
 
D
 
M9) was injected into the cy-
toplasm of 
 
Xenopus leavis
 
 oocytes. After 4 h, oocytes were
dissected into nuclear and cytoplasmic fractions and ana-
lyzed by SDS-PAGE followed by fluorography. Approxi-
mately 50% of the injected hnRNP A1 was imported into
the nucleus, while the A1
 
D
 
M9 mutant remained entirely in
the cytoplasm (Fig. 1, lanes 
 
4–6
 
). The M9 domain is there-
fore essential for the nuclear uptake of A1.
Next we tested whether the M9 domain is also sufficient
to target an otherwise cytoplasmic protein to the nucleus.
For this purpose, hnRNP A1 amino acids 255–320, includ-
ing the M9 domain, were fused to the NPLc. The NPLc is
able to form multimers larger than the exclusion size limit
for free diffusion through nuclear pore complexes. Thus,
only in the presence of an appropriate signal can NPLc be
transported across the nuclear envelope (Dingwall et al.,
1982). The fusion protein (NPLc-M9) was produced by
translation in vitro and injected into the oocyte cytoplasm.
NPLc-M9 was transported to the nucleus with an effi-
ciency similar to that of full length hnRNP A1 (Fig. 1,
lanes 
 
4–6
 
). Similar results were obtained in experiments
carried out with fusions of M9 (A1 aa268–305) to either
the cytoplasmic protein pyruvate kinase (PK-M9; see Fig. 3)
or to the bacterial protein GST-M9 (data not shown).
Thus, M9 is sufficient to mediate nuclear import of a pro-
tein in both somatic cells and 
 
Xenopus
 
 oocytes.
To determine whether M9-mediated protein import is
saturable and hence a receptor-mediated process, 
 
35
 
S-
labeled, in vitro translated hnRNP A1 was injected into
Figure 1. The hnRNP A1 M9 domain mediates nuclear import in
Xenopus oocytes. Xenopus laevis oocytes were injected into the
cytoplasm with the following in vitro translated 35S-labeled pro-
teins: full length human hnRNP A1 (aa1-320), hnRNP A1DM9, a
truncated form of A1 lacking the M9 domain (aa1-236), and
NPLc-M9, a nucleoplasmin core–M9 fusion (A1 aa255-320), as
indicated. In lanes 1–3, proteins were extracted immediately after
injection and in lanes 4–6, 4 h after injection. T, C, and N indicate
proteins extracted from total oocytes or after dissection from cy-
toplasmic or nuclear fractions, respectively. Proteins were ana-
lyzed by SDS-PAGE followed by fluorography. 
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the cytoplasm of oocytes either without a competitor (Fig.
2, lanes 
 
1
 
 and 
 
2
 
) or along with either bacterially expressed
GST-M9 (A1 aa268–305) fusion (Fig. 2, lanes 
 
5
 
 and 
 
6
 
) or
GST fused to an inactive mutant of M9 (termed GST-
M9mu in which Gly 274 has been mutated to Ala; Fig. 2,
lanes 
 
3
 
 and 
 
4
 
). Transport was analyzed 5 h later. While
GST-M9mu did not interfere with A1 import (Fig. 2, com-
pare lanes 
 
1
 
 and 
 
2
 
 and 
 
3
 
 and 
 
4
 
), GST-M9 strongly inhib-
ited the import of A1 (Fig. 2, lanes 
 
5
 
 and 
 
6
 
). The inhibition
was dependent on the concentration of GST-M9 used and
was overcome after prolonged incubation (data not
shown), indicating that GST-M9 is a competitive inhibitor
of hnRNP A1 import. Thus, M9 accesses a saturable and
therefore receptor-mediated import pathway in oocytes.
 
M9 Does Not Use the Classical NLS-mediated
Import Pathway
 
The saturability of the M9-mediated transport pathway al-
lowed us to ask whether M9 accesses the two previously
described import pathways used by either proteins con-
taining a classical NLS (the importin pathway) or by spli-
ceosomal m
 
3
 
G-capped U snRNAs, respectively. To address
this issue we first tested the effect of a large excess of unla-
beled GST-M9 on the import kinetics of pyruvate kinase
fused to a classical bipartite basic NLS derived from the
hnRNP protein K (PK-NLS; Michael et al., 1995
 
b
 
). PK-
NLS was translated in vitro and injected into the oocyte
cytoplasm either without competitor or with a large excess
of GST-M9 or GST-M9mu (Fig. 3, lanes 
 
1–6
 
). Nuclear im-
port was analyzed 5 h later. In a parallel experiment the ef-
fect of the competitor on the import of labeled PK-M9 was
tested (Fig. 3, lanes 
 
7–12
 
). As shown in Fig. 3, GST-M9
efficiently blocked PK-M9 import, but the nuclear uptake
of PK-NLS was not affected. These results suggest that the
factor titrated by the excess of GST-M9 is not essential for
NLS-mediated import but do not unequivocally exclude the
possibility that the NLS is recognized by the same receptor
as M9, but with a higher affinity. We therefore investi-
gated whether M9-mediated import is affected by inhibi-
tors of the NLS pathway. The inhibitors were coinjected
into the oocyte cytoplasm along with two 
 
35
 
S-labeled pro-
teins, the 80-kD subunit of the cap binding complex
(CBP80), and hnRNP A1. CBP80 has a canonical bipartite
NLS (Izaurralde et al., 1995
 
b
 
) and therefore was used as
an indicator of NLS-dependent import. hnRNP A1 con-
tains the M9 domain and is imported by virtue of this sig-
nal. First, NLS peptides crosslinked to BSA (BSA–NLS), a
well characterized competitive inhibitor of NLS-dependent
import (Goldfarb et al., 1986), was tested. As expected,
the import of CBP80 was specifically inhibited when BSA–
NLS was injected along with the 
 
35
 
S-labeled proteins into
the cytoplasm of oocytes. In contrast, the import of A1
was not affected (Fig. 4, lanes 
 
16–18
 
). BSA coupled to
peptides whose sequence is the reverse of the NLS (BSA-
NLSrev), failed to inhibit the import of CBP80 (Fig. 4,
lanes 
 
13–15
 
).
The NLS import receptor is a heterodimer of the impor-
tin 
 
a
 
 and 
 
b
 
 proteins. Importin 
 
a
 
 binds directly to the NLS
and interacts with importin 
 
b
 
 via its NH
 
2
 
-terminal or IBB
domain (Görlich et al., 1996
 
a
 
; Weis et al., 1996). Polypep-
tides corresponding to the IBB domain served as efficient
inhibitors of NLS-mediated import by preventing interac-
tion between the subunits. Coinjection of IBB together
with CBP80 and hnRNP A1 efficiently and specifically in-
hibited the import of CBP80 but not of A1 (Fig. 4, lanes
 
10–12
 
). As a control, a truncated form of the IBB domain
(IBB trunc) which is unable to interact with importin b,
did not affect the nuclear accumulation of either CBP80 or
A1 (Fig. 4, lanes 7–9). Taken together, these data show
that M9 accesses an import pathway that is different from
that utilized by proteins containing a classical, basic NLS,
and is independent of importin a.
Saturation of M9-mediated Transport Does Not 
Interfere with the Import of Spliceosomal U snRNAs
We wished next to analyze whether M9 accesses a second
import pathway that has been described, namely that of
m3G-capped spliceosomal U snRNAs. The spliceosomal
snRNAs U1, U2, U4, and U5 were 39 end labeled and in-
jected into the cytoplasm of oocytes either without com-
petitor or with an excess of GST-M9mu or GST-M9. Im-
Figure 2. M9-mediated nu-
clear import is saturable. In
vitro translated 35S-labeled
hnRNP A1 (A1) was injected
into  Xenopus laevis oocyte
cytoplasm either without
competitor (lanes 1 and 2) or
with bacterially expressed
GST-M9 mutant fusion (A1
aa268-305, Gly 274 mutated
to Ala; GST-M9mu; lanes 3
and  4) or GST-M9 fusion
(A1 aa268-305; lanes 5 and
6). The concentration of re-
combinant proteins in the in-
jected samples was 10 mg/ml,
and the final concentration in the oocyte is 5–10% of this value.
Transport was analyzed after 5 h incubation as described in Fig. 1.
Figure 3. Saturation of the M9 import pathway does not interfere
with NLS-mediated import. In vitro translated 35S-labeled PK-
NLS and PK-M9 (A1 aa268-305) were injected into the cytoplasm
of Xenopus laevis oocytes either without competitor (lanes 1 and
2 and 7 and 8) or with bacterially expressed recombinant GST-M9
(lanes 5 and 6 and 11 and 12) or GST-M9mu (lanes 3 and 4 and 9
and 10). Lanes 13 and 14 show in vitro translated PK-NLS and
PK-M9, respectively. The concentration of recombinant proteins
in the injected samples was 10 mg/ml. Transport was analyzed 5 h
after injection as described in Fig. 1.Izaurralde et al. hnRNP A1 M9 Domain and mRNA Export 31
port was analyzed 3 and 12 h later. The four U snRNAs
were imported with approximately the same efficiency
(Fig. 5, lanes 1–5), and their import kinetics were not af-
fected by either GST-M9 or GST-M9mu (Fig. 5, lanes 6–
10 and 11–15, respectively). We conclude that the spliceo-
somal U snRNA import pathway and the M9-mediated
import pathway require different limiting transport factors.
M9-mediated Transport Is Directly Linked to
mRNA Export
Available data provide strong evidence for the existence
of a specific, mRNA nuclear export pathway (see Intro-
duction). If the transport pathway that is accessed by M9-
containing proteins is important for mRNA export one
would predict that specific interference with hnRNP A1
transport should also interfere with mRNA export but not
with the export of other RNAs. Conversely, inhibitors of
the importin a/b pathway, as shown in Fig. 4, that do not
interfere with M9-mediated import should not affect
mRNA export.
It has previously been shown that inhibitors of importin-
mediated nuclear protein import inhibit U snRNA export
(Görlich et al., 1996b). To test whether they also affect
mRNA export, the inhibitors described in Fig. 4 were pre-
injected into Xenopus oocyte cytoplasm. 1 h later the oo-
cytes received a nuclear injection of a mixture of 32P-labeled
DHFR mRNA, U1DSm, U5DSm, tRNA, and U6Dss. U6Dss
serves as a control for nuclear injection, as this RNA is not
exported to the cytoplasm, while the other RNAs are ex-
ported via specific pathways. After 150 min incubation the
oocytes were dissected into nuclear and cytoplasmic frac-
tions and the RNAs analyzed on denaturing polyacryla-
mide gels.
As expected, U snRNA export was inhibited by cyto-
plasmic injection of the IBB domain (Görlich et al., 1996b).
At the concentration at which the IBB domain completely
abolishes U snRNA export (Fig. 6, lanes 10–12) and also
NLS-mediated import (see Fig. 4), mRNA export is only
slightly affected (Fig. 6, lanes 10–12). In this experiment,
IBB injection also partially inhibited tRNA export. In
other experiments, where lower amounts of IBB were in-
jected, U snRNA export was inhibited while DHFR mRNA
and tRNA export were not affected (Görlich et al., 1996b
and data not shown). Saturating amounts of BSA-NLS
peptide conjugate (Fig. 4) did not affect tRNA export but
reduced U snRNA export by 55% and mRNA export by
20% (Fig. 6, lanes 16–18). In summary, the different sensi-
tivities of mRNA and U snRNA export to the presence of
the IBB domain or to BSA-NLS conjugate are consistent
with previously published data that demonstrated the
existence of a specific mRNA export pathway. The minor
effect on mRNA export of inhibitors of the classical NLS-
mediated protein import pathway indicate that such pro-
teins play only a minor kinetic role in mRNA export.
To investigate if proteins carrying an M9 domain play a
role in mRNA export, we injected full length hnRNP A1
into the cytoplasm and analyzed its effect on RNA export.
1 h after injection of hnRNP A1 in the cytoplasm, a mix-
ture of DHFR mRNA, U1DSm, U5DSm, U6Dss, and tRNA
were injected to the nucleus, and export was analyzed 150
min later. hnRNP A1 injection specifically inhibited
mRNA export (Fig. 7 A, compare lanes 4–6 with 7–9). In
Figure 4. M9-mediated import is importin a independent. Xeno-
pus laevis oocytes were injected into the cytoplasm with a mixture
of labeled CBP80 and hnRNP A1 as indicated. In lanes 1–6, la-
beled proteins were diluted in PBS; in lanes 7–18 the labeled pro-
teins were coinjected with the inhibitors indicated above the
lanes. Bacterially expressed recombinant IBB (lanes 10–12) or
truncated IBB (IBB trunc; lanes 7–9) were injected at a concen-
tration of 20 mg/ml. The concentration of the BSA-NLS peptide
conjugate (lanes 16–18) or of the BSA crosslinked to the reverse
NLS peptide (BSA-NLSrev; lanes 13–15) was 20 mg/ml in the in-
jection mixtures. Protein samples from total oocytes (T) or cyto-
plasmic (C) and nuclear (N) fractions were collected 5 h after in-
jection in lanes 4–18 or immediately after injection in lanes 1–3.
Proteins were analyzed as described in Fig. 1.
Figure 5. Saturation of M9-
mediated import does not in-
terfere with nuclear uptake of
U snRNAs. 32pCp-labeled
U1, U2, U4, and U5 snRNAs
were injected into the cyto-
plasm of oocytes either with-
out competitor (lanes 1–5) or
together with 10 mg/ml of re-
combinant GST-M9mu (lanes 6–10) or GST-M9 (lanes 11–15).
Oocytes were dissected 3 or 12 h after injection as indicated, and
RNA was analyzed on denaturing polyacrylamide gels. Lanes 1,
6, and 11 were loaded with RNA extracted from total oocytes im-
mediately after injection.
Figure 6. Inhibitors of basic NLS import differentially affect U
snRNA and mRNA export. Xenopus leavis oocytes were injected
into the cytoplasm with the inhibitors indicated above the lanes.
As a control, oocytes were injected with PBS alone (lanes 1–6).
After 1 h incubation a second microinjection was performed into
the oocyte nuclei with a mixture of the following radioactively la-
beled RNAs: DHFR mRNA, U1DSm, U5DSm, U6Dss, and hu-
man initiator methionyl tRNA. U6Dss does not leave the nucleus
and is an internal control for nuclear integrity. Synthesis of DHFR,
U1DSm, and U5DSm RNAs was primed with the m7GpppG cap
dinucleotide, whereas synthesis of U6Dss RNA was primed with
g-mGTP. In lanes 4–18 RNA was extracted 150 min after injec-
tion; in lanes 1–3, RNA was extracted immediately after injec-
tion. The concentration of the inhibitors in the injected samples
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separate experiments we determined that cytoplasmic in-
jection of A1DM9, which lacks the M9 domain but is fully
functional in nonspecific RNA binding, has no effect on
mRNA export (data not shown).
Analysis of M9-mediated protein import in the presence
of the amount of hnRNP A1 used in Fig. 7 A revealed only
a partial block (data not shown) suggesting that the inhibi-
tory effect may be directly on mRNA export rather than
an indirect consequence of inhibiting M9-mediated im-
port. To examine this question further, increasing amounts
of recombinant hnRNP A1 or, as control, A1DM9 were in-
jected into oocyte nuclei 1 h before injection of the labeled
RNAs. After an additional 150 min, RNA export was ana-
lyzed. In control oocytes that were preinjected with PBS,
90% of the DHFR mRNA and 70% of the two U snRNAs
moved to the cytoplasm. tRNA export was complete (Fig.
7 B, lanes 16–18). Nuclear preinjection of A1DM9 did not
interfere with the export of any of these RNAs (Fig. 7 B,
lanes 7–9 and 13–15). However, preinjection of hnRNP A1
very efficiently inhibited nuclear export of mRNA (Fig. 7 B,
lanes  4–6 and 10–12). The inhibition was specific for
mRNA since neither tRNA nor U snRNA export was af-
fected. The effect was not specific to DHFR mRNA, since
export of other microinjected mRNAs was similarly inhib-
ited by hnRNP A1 injection (data not shown). The com-
parison of the full length and truncated A1 proteins pro-
vides strong evidence that the M9 domain is required for
interaction with the factor(s) saturated by hnRNP A1 in-
jection. Surprisingly, however, we found that injection of
either a GST–M9 fusion protein (A1 aa268-305) or a nu-
cleoplasmin–M9 fusion protein (A1 aa255-320) into either
the nucleus or cytoplasm did not result in inhibition of
mRNA export, even at a concentration sufficient to com-
pletely block M9-mediated protein import (data not
shown). This suggested that the factor(s) required for
mRNA export that are saturated by hnRNP A1 injection
recognize the A1 protein via a more extensive interaction
than is conferred by the M9 domain alone.
To further investigate the recognition of hnRNP A1 by
export factors, we first tested a second A1 truncation mu-
tant (A1 aa1-267) that removed the M9 domain but no
amino acids NH2-terminal to it. This protein, like hnRNP
A1DM9, had no effect on mRNA export (data not shown),
providing strong support for the hypothesis that M9 recog-
nition is required but not sufficient to saturate mRNA ex-
port. These results suggest that hnRNP A1 recognition
during mRNA export is not identical to that which occurs
during protein import and export, for which the M9 signal
is sufficient (Michael et al., 1995b; Siomi et al., 1995). To
provide additional evidence for this conclusion we tested
the effect of the Gly 274 to Ala point mutation (hnRNP
A1-M9mu), which abolishes the function of M9 in import
(Siomi et al., 1995) and hnRNP A1 shuttling (Michael et
al., 1995b). Like hnRNP A1 itself (Fig. 7 C, compare lanes
4–6 with 7–9), microinjection of the hnRNP A1-M9mu
protein into the nucleus reproducibly caused a strong, spe-
cific inhibition of mRNA export (Fig. 7 C, lanes 10–12).
Discussion
In this study we analyzed the hnRNP A1 transport path-
way in oocytes. Consistent with previous results obtained
in somatic cells, we found that the M9 domain of A1 is
necessary and sufficient to mediate nuclear import. More-
over, it was possible to show that the M9-mediated import
pathway is saturable and hence a receptor-mediated pro-
Figure 7. The M9 domain is required to specifically saturate the
mRNA export pathway. (A) Recombinant hnRNP A1 protein at
2 mg/ml was injected into oocyte cytoplasm. Control oocytes re-
ceived a PBS injection. After 1 h incubation, the oocytes received
a nuclear injection of the same mixture of radioactively labeled
RNAs described in Fig. 6. Dissection was performed after 150 min
in lanes 4–9 or immediately after injection in lanes 1–3. (B) Re-
combinant hnRNP A1 or hnRNP A1DM9 were injected into oo-
cyte nuclei as indicated above the lanes. After 1 h incubation, a
second microinjection was performed into the oocyte nuclei with
the same mixture of the radioactively labeled RNAs described in
Fig. 6. In lanes 4–18 RNA was extracted 150 min after injection;
in lanes 1–3, RNA was extracted immediately after injection. The
concentrations of the recombinant proteins in the injected sam-
ples were as indicated above the lanes. (C) Recombinant hnRNP
A1 or hnRNP A1-M9mu (Gly 274 ® Ala) was injected into oo-
cyte nuclei 1 h before a mixture of radioactively labeled RNAs
(Fig. 6). In lanes 1–3, RNA was extracted immediately after injec-
tion; in lanes 4–12 dissection and RNA extraction was 160 min af-
ter injection. The concentration of recombinant proteins in the
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cess. Competition studies allowed comparison of M9-
mediated import with previously characterized import
pathways. Interestingly, the limiting factors that are in-
volved in the nuclear import of proteins with the well stud-
ied basic types of NLS appear to not be required for M9-
mediated import. In particular, we failed to saturate the
import mediated by a bipartite (nucleoplasmin-type) NLS
by coinjection of GST-M9 while under the same condi-
tions M9-mediated import was completely blocked. Con-
versely, we did not observe any inhibition of the M9-medi-
ated import pathway by a BSA-NLS conjugate under
conditions where the conjugate saturates the basic NLS-
mediated import pathway. Finally, IBB, the importin b
binding domain of importin a, which has recently been
shown to block the interaction between importin a and b
and therefore serves as a potent inhibitor of the classical
NLS-mediated import pathway (Görlich et al., 1996a;
Weis et al., 1996) did not interfere with M9 import. These
data were obtained in parallel with those of Pollard et al.
(1996). By analysis of protein import into the nuclei of per-
meabilized mammalian cells in vitro these investigators
showed that, unlike classical NLS-mediated import, M9-
mediated import does not require either importin a or b.
They identified a protein, transportin, that interacts with
the M9 domain and mediates import of M9-containing
proteins into the nucleus (Pollard et al., 1996).
The import of spliceosomal m3G-capped U snRNPs has
previously been shown not to be dependent on saturable
factors required for the classical NLS-mediated import
pathway (Fischer et al., 1991, 1993; Michaud and Gold-
farb, 1991; van Zee et al., 1993). Injection of saturating
amounts of a GST-M9 fusion protein failed to inhibit the
import of a mixture of four U snRNAs, indicating that M9
does not interact with limiting factors required for U sn-
RNP import. We conclude from the two sets of data on
specific crosscompetition and on the basis of the data in
Pollard et al. (1996) that the M9 domain represents a new
class of NLS that accesses a novel import pathway. Given
the fact that other hnRNP proteins are imported into the
nucleus but appear to lack either a classical NLS or an M9-
type NLS it is to be expected that additional signal recep-
tor systems for nuclear import may exist.
The M9 Domain and mRNA Export
Study of RNA export has led to the understanding that
protein import into the nucleus and RNA export from the
nucleus are intimately related processes. The first indica-
tion that this is the case came from the observation that
proteins proposed to serve in RNA export are not perma-
nently nuclear but rather shuttle continuously between the
nucleus and cytoplasm. Examples are some hnRNP pro-
teins (Piñol-Roma and Dreyfuss, 1991, 1992, 1993; Michael
et al., 1996a) or the HIV-1 Rev protein (Kalland et al., 1994;
Meyer and Malim, 1994). More recently, it was observed
that inhibition of the basic NLS-mediated protein import
pathway inhibits specifically the export of U snRNAs from
the nucleus (Görlich et al., 1996b). This inhibition is not a
direct effect on export but rather appears to reflect deple-
tion of the nuclear pool of an NLS-bearing protein re-
quired for U snRNA export. The data presented here
show that inhibitors of basic NLS-mediated import have
only a minor kinetic effect on mRNA export. This indi-
cates that basic NLS-bearing proteins likely play only a
minor role in mRNA export. Previous data have shown
that the mRNA cap structure has a similar minor effect on
the mRNA export rate (Jarmolowski et al., 1994), suggest-
ing that the observed effect might be due to the nuclear
cap-binding complex, which has a bipartite basic NLS (Iza-
urralde et al., 1994, 1995b; Kataoka et al., 1994) and ac-
companies the mRNA to the cytoplasm (Visa et al., 1996b).
A much greater effect on mRNA export was obtained
when hnRNP A1 protein was injected. Injection of full
length hnRNP A1 into either the nucleus or the cytoplasm
resulted in mRNA export inhibition, whereas injection
into either location of hnRNP A1 truncation mutants lack-
ing the M9 domain had no effect. This suggests that recog-
nition of M9 is involved in the interaction between hnRNP
A1 and the mRNA export mediator which is saturated by
A1 injection. However, since an M9-containing fusion pro-
tein was unable to inhibit mRNA export, even at a concen-
tration which blocked M9-mediated protein import, M9
recognition alone is insufficient to explain the effect of
hnRNP A1 on mRNA export. Furthermore, a point muta-
tion in the M9 domain (Gly 274 to Ala) that is sufficient to
inactivate the M9 signal when either protein import or
protein shuttling (nuclear export followed by reimport)
was measured (Michael et al., 1995b; Siomi et al., 1995) did
not prevent saturation of the mRNA export pathway.
These data, in sum, suggest that the recognition of hnRNP
A1 during mRNA export is not identical to its recognition
during protein transport.
The nuclear import of hnRNP A1 is mediated by trans-
portin (Pollard et al., 1996). Our data show that recogni-
tion of the M9 domain is required but not sufficient to sat-
urate the mRNA export pathway. We can suggest two
possible model explanations for this. The first invokes a
factor required for mRNA export distinct from transpor-
tin that would bind cooperatively to hnRNP A1 with
transportin and stabilize its binding such that the Gly to
Ala mutation is insufficient to prevent recognition. The
second would propose that an mRNA export factor dis-
tinct from transportin would recognize hnRNP A1 in a
way that requires the M9 domain but also additional amino
acids lying NH2-terminal to the M9 domain. Since M9 is
sufficient to direct protein export from the nucleus
(Michael et al., 1995b) the first model seems more plausi-
ble, but further study is required to distinguish the possi-
bilities.
HnRNP A1 injection specifically inhibited mRNA ex-
port and had no effect on either U snRNA or tRNA ex-
port, while inhibitors of the importin a/b pathway specifi-
cally block U snRNA export (Görlich et al., 1996b and this
investigation). These results confirm and extend the con-
clusion reached by microinjection of different RNAs (Jar-
molowski et al., 1994) that different specific factors medi-
ate the export of different classes of RNAs from the nucleus.
The results from Jarmolowski et al. (1994) could have
been explained by the existence of factors that had differ-
ent RNA binding specificity but interacted with a common
export mediator. However, the observation that conju-
gates of Rev NES peptides and BSA specifically inhibited
U snRNA export without affecting mRNA export (Fischer
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(1996b) and this investigation make it obvious that the dif-
ferences in the factors involved in RNA class-specific ex-
port are more extensive. Our present knowledge allows us
to distinguish at least two independent transport path-
ways: one defined by importin a/b that is somehow linked
to U snRNA and Rev NES-mediated export and a second
defined by the M9 domain, which is linked to mRNA export.
Is Npl3p/Nop3p the Functional Homologue of 
hnRNP A1?
It is of interest to compare transport behavior of the
hnRNP A1 protein and its effect on mRNA export with
the data on the yeast Npl3p/Nop3p protein (Flach et al.,
1994; Wilson, et al., 1994; Russell and Tollervey, 1995; Sin-
gleton et al., 1995). This protein is related in sequence to
hnRNP A1, and mutation of the protein affects the export
of polyadenylated (m)RNA from the nucleus of yeast cells
(Russell and Tollervey, 1995; Singleton et al., 1995). Muta-
tion of Npl3p/Nop3p also affects protein import into the
yeast nucleus (Bossie et al., 1992). However there are crit-
ical differences between the two proteins. The first is that
mutations in Npl3p/Nop3p affect the import of classical NLS-
bearing proteins in yeast (Bossie et al., 1992) whereas we
show here that the M9 domain saturates an import path-
way that is apparently distinct from that used by proteins
with a classical basic NLS. Secondly, the export of Npl3p/
Nop3p from the nucleus requires continuous transcription
of RNA, consistent with the idea that Npl3p/Nop3p leaves
the nucleus only in association with RNA (Lee et al., 1996).
hnRNP A1, on the other hand, leaves the nucleus inde-
pendent of ongoing transcription, but surprisingly, its nu-
clear import is transcription dependent (Piñol-Roma and
Dreyfuss, 1991, 1992, 1993). These data suggest that al-
though the hnRNP A1 and Npl3p/Nop3p proteins may
well have analogous functions in vertebrates and yeast, re-
spectively, the detailed mechanism by which they act and
through which they exercise their functions are likely to
exhibit considerable differences.
In conclusion, we provide evidence for the existence of a
novel saturable factor involved in the nuclear import of a
specific subclass of nuclear proteins, namely hnRNP A1
and other proteins carrying the M9 domain. Moreover,
our data suggest a direct link between recognition of M9 in
the context of the hnRNP A1 protein and mRNA export,
consistent with previous suggestions that hnRNP A1 may
interact with factors required for the export of mRNA
from the nucleus.
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